Evidence map›Paper›PMID 36833372›Full record

ArticleGenes2023

Pharmacogenetic Analysis of the

Paraskevi Nani, Melpomeni Ladopoulou, Evgenia H Papaioannou, Evangelia D Papagianni, Charalabos Antonatos, Panagiotis Xiropotamos, Andreas Kapsoritakis, Petros S Potamianos, Konstantinos Karmiris, Charalambos Tzathas and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Paraskevi NaniLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-9530-1997
Melpomeni LadopoulouLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.ORCID 0000-0003-2775-7479
Evgenia H PapaioannouLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-8912-6379
Evangelia D PapagianniLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.ORCID 0000-0001-6688-6199
Charalabos AntonatosLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-5967-9367
Panagiotis XiropotamosLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.ORCID 0000-0003-4244-5940
Andreas KapsoritakisGastroenterology Department, University General Hospital of Larissa, 41110 Larissa, Greece.
Petros S PotamianosGastroenterology Department, University General Hospital of Larissa, 41110 Larissa, Greece.
Konstantinos KarmirisGastroenterology Department, "Venizeleio Pananeio" General Hospital of Heraklion, 71409 Heraklion, Greece.
Charalambos TzathasGastroenterology Department, "Tzaneio" General Hospital of Piraeus, 18536 Athens, Greece.
Aikaterini Patsatsi2nd Dermatology Department, Medical School, Papageorgiou Hospital, Aristotle University, 56403 Thessaloniki, Greece.ORCID 0000-0001-9616-2001
Elisavet Lazaridou2nd Dermatology Department, Medical School, Papageorgiou Hospital, Aristotle University, 56403 Thessaloniki, Greece.
Efterpi ZafiriouBioPsorAD Consortium, 26504 Patras, Greece.
Angeliki Roussaki-SchulzeBioPsorAD Consortium, 26504 Patras, Greece.
Sophia GeorgiouBioPsorAD Consortium, 26504 Patras, Greece.
Katerina GrafanakiBioPsorAD Consortium, 26504 Patras, Greece.
Georgios K GeorgakilasLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.
Yiannis VasilopoulosLaboratory of Genetics, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, 26504 Patras, Greece.
University of Patras · GRUniversity of Thessaly · GRPapageorgiou General Hospital · GRUniversity Hospital of Larissa · GRThe General Hospital of Heraklion "Venizeleio-Pananio" · GRTzaneion General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical heterogeneity regarding the response profile of the antitumor necrosis factor (anti-TNF) in patients with Crohn's disease (CD) and psoriasis (PsO) is attributed, amongst others, to genetic factors that influence the regulatory mechanisms which orchestrate the inflammatory response. Here, we investigated the possible associations between the

Indexed as

Crohn DiseaseMicroRNAsPsoriasisHumansPharmacogenomic TestingPolymorphism, GeneticTumor Necrosis Factor InhibitorsMicroRNAsMIRN155 microRNA, humanTumor Necrosis Factor Inhibitorsanti-TNFCrohn’s diseasemiRNApharmacogeneticspsoriasisresponse to therapy

Identifiers

PMID36833372
PMCPMC9957441
OpenAlexW4319985710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.